| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
2 companies
Bratton Douglas K is a 10% Owner at Denali Therapeutics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 19 sells.
Estimated insider holdings value: $233.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2021 | DNLI Denali Therapeutics Inc. | 10% Owner | Sell | 2,216,798 | $65.00 | $144,091,870.00 | -18.2% | |
| Dec 14, 2020 | DNLI Denali Therapeutics Inc. | 10% Owner | Sell | 64,624 | $80.14 | $5,179,284.87 | -5.2% | |
| Aug 12, 2020 | DNLI Denali Therapeutics Inc. | 10% Owner | Sell | 1,443,247 | $31.65 | $45,678,767.55 | -10.6% | |
| Jun 30, 2020 | DNLI Denali Therapeutics Inc. | 10% Owner | Sell | 250,000 | $23.97 | $5,993,051.59 | -7.5% | |
| Jun 23, 2020 | DNLI Denali Therapeutics Inc. | 10% Owner | Sell | 255,000 | $24.72 | $6,304,373.01 | -5.3% | |
| Jun 5, 2020 | DNLI Denali Therapeutics Inc. | 10% Owner | Sell | 1,922,855 | $25.75 | $49,513,516.25 | -12.4% | |
| Feb 26, 2020 | DNLI Denali Therapeutics Inc. | 10% Owner | Sell | 3,894,764 | $20.25 | $78,868,971.00 | -20.0% | |
| Jul 24, 2018 | AQST Aquestive Therapeutics, Inc. | Director, 10% Owner | Buy | 165,000 | $15.00 | $2,475,000.00 | New | |
| Dec 12, 2017 | DNLI Denali Therapeutics Inc. | 10% Owner | Buy | 275,000 | $18.00 | $4,950,000.00 | +1.4% |